Neuland Laboratories Limited (NEULANDLAB.NS)
INR 11154.3
(-2.17%)
INR 11154.3
(-2.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.31 Billion INR | 74.75% |
| 2022 | 2.3 Billion INR | 139.94% |
| 2021 | 960.9 Million INR | -12.35% |
| 2020 | 1.09 Billion INR | 48.96% |
| 2019 | 735.98 Million INR | 91.43% |
| 2018 | 384.47 Million INR | 32.55% |
| 2017 | 290.06 Million INR | -59.1% |
| 2016 | 709.15 Million INR | 9.12% |
| 2015 | 649.86 Million INR | 32.76% |
| 2014 | 489.51 Million INR | -11.08% |
| 2013 | 550.48 Million INR | 24.58% |
| 2012 | 441.89 Million INR | 33.71% |
| 2011 | 330.48 Million INR | 2.03% |
| 2010 | 323.9 Million INR | 134.22% |
| 2009 | 138.29 Million INR | -37.73% |
| 2008 | 222.08 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.07 Billion INR | 18.38% |
| 2023 Q2 | 1.26 Billion INR | 51.23% |
| 2023 Q1 | 833.34 Million INR | -27.19% |
| 2023 Q4 | 904.54 Million INR | -16.42% |
| 2023 FY | 4.02 Billion INR | 74.75% |
| 2023 Q3 | 1.08 Billion INR | -14.13% |
| 2022 Q4 | 1.14 Billion INR | 174.6% |
| 2022 Q2 | 563.64 Million INR | 256.61% |
| 2022 FY | 2.3 Billion INR | 139.94% |
| 2022 Q1 | 158.05 Million INR | -50.17% |
| 2022 Q3 | 416.8 Million INR | -26.05% |
| 2021 Q1 | 138.6 Million INR | -17.56% |
| 2021 FY | 960.9 Million INR | -12.35% |
| 2021 Q3 | 196.57 Million INR | -36.28% |
| 2021 Q4 | 317.2 Million INR | 61.37% |
| 2021 Q2 | 308.51 Million INR | 122.59% |
| 2020 Q2 | 315.92 Million INR | 26.46% |
| 2020 FY | 1.09 Billion INR | 48.96% |
| 2020 Q4 | 168.12 Million INR | -53.55% |
| 2020 Q3 | 361.91 Million INR | 14.56% |
| 2020 Q1 | 249.81 Million INR | 3.34% |
| 2019 Q3 | 203.41 Million INR | 22.05% |
| 2019 FY | 735.98 Million INR | 91.43% |
| 2019 Q4 | 241.74 Million INR | 18.84% |
| 2019 Q2 | 166.67 Million INR | 50.03% |
| 2019 Q1 | 111.09 Million INR | -34.1% |
| 2018 Q3 | 86.07 Million INR | -3.11% |
| 2018 Q2 | 88.83 Million INR | 155.61% |
| 2018 Q1 | 34.75 Million INR | 0.0% |
| 2018 FY | 384.47 Million INR | 32.55% |
| 2018 Q4 | 168.59 Million INR | 95.88% |
| 2017 FY | 290.06 Million INR | -59.1% |
| 2016 Q4 | 323.16 Million INR | 115.27% |
| 2016 Q3 | 150.12 Million INR | -27.37% |
| 2016 Q2 | 206.69 Million INR | 1.14% |
| 2016 FY | 709.15 Million INR | 9.12% |
| 2016 Q1 | 204.35 Million INR | 0.0% |
| 2015 FY | 649.86 Million INR | 32.76% |
| 2014 FY | 489.51 Million INR | -11.08% |
| 2013 FY | 550.48 Million INR | 24.58% |
| 2012 FY | 441.89 Million INR | 33.71% |
| 2011 FY | 330.48 Million INR | 2.03% |
| 2010 FY | 323.9 Million INR | 134.22% |
| 2009 FY | 138.29 Million INR | -37.73% |
| 2008 FY | 222.08 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -187763.613% |
| Aarti Drugs Limited | 7.14 Billion INR | 25.608% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -70.009% |
| Ajanta Pharma Limited | 19.67 Billion INR | 72.973% |
| Alembic Limited | 767.77 Million INR | -592.667% |
| Alkem Laboratories Limited | 19.46 Billion INR | 72.674% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 7.642% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -18.869% |
| Bal Pharma Limited | 214.56 Million INR | -2378.5% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -25645.991% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -332.014% |
| Brooks Laboratories Limited | -72.25 Million INR | 7460.477% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -2137.68% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 26.396% |
| Divi's Laboratories Limited | 18.31 Billion INR | 70.955% |
| Eris Lifesciences Limited | 5.18 Billion INR | -2.632% |
| Granules India Limited | 6.52 Billion INR | 18.537% |
| Ind-Swift Limited | 1.22 Billion INR | -333.789% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -2384.625% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 29.484% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -2.488% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2456.161% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 277.11 Million INR | -1819.071% |
| Wockhardt Limited | 140 Million INR | -3698.637% |
| Orchid Pharma Limited | 2.36 Billion INR | -125.24% |
| RPG Life Sciences Limited | 2.29 Billion INR | -131.998% |
| Shilpa Medicare Limited | 3.76 Billion INR | -41.38% |
| Sigachi Industries Limited | 1.47 Billion INR | -260.819% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 238.028% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -84394.63% |
| Wanbury Limited | 1.7 Billion INR | -211.508% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 88.284% |
| FDC Limited | 3.03 Billion INR | -75.298% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -756.338% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 92.148% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 40.773% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -164.709% |
| Laurus Labs Limited | 3.94 Billion INR | -34.683% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -19268.097% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -36.691% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -864.14% |
| Hester Biosciences Limited | 364.77 Million INR | -1357.93% |
| Ipca Laboratories Limited | 29.59 Billion INR | 82.031% |
| Venus Remedies Limited | 534.65 Million INR | -894.685% |
| ZIM Laboratories Limited | 1.09 Billion INR | -384.294% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 94.911% |
| Morepen Laboratories Limited | 4.17 Billion INR | -27.415% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -15.419% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Windlas Biotech Limited | 1.29 Billion INR | -309.434% |
| Hikal Limited | 1.49 Billion INR | -255.916% |
| Innova Captab Limited | 2.53 Billion INR | -109.918% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -90.886% |
| Themis Medicare Limited | 1.3 Billion INR | -308.109% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -7.606% |
| Mankind Pharma Limited | 40.86 Billion INR | 86.987% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 18.213% |
| Sakar Healthcare Limited | 495.5 Million INR | -973.265% |
| Albert David Limited | 1.33 Billion INR | -298.521% |
| Lupin Limited | 27.75 Billion INR | 80.841% |
| Gufic Biosciences Limited | 2.89 Billion INR | -83.775% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 94.901% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -178.97% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -2033.629% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 79.009% |
| NATCO Pharma Limited | 25.96 Billion INR | 79.516% |
| Suven Life Sciences Limited | -1.22 Billion INR | 533.839% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -1.766% |
| Indoco Remedies Limited | 1.52 Billion INR | -248.865% |
| Alpa Laboratories Limited | 61.51 Million INR | -8545.195% |
| Lasa Supergenerics Limited | -458 Million INR | 1261.143% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 229.235% |